Mansberger Steve L

Outcomes of the Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation Treatment Study: A Randomized Comparative Trial.

Short-term overall success rates were high with either SGDD or CPC. However, SGDD was associated with more clinic visits and an increased risk of additional glaucoma surgery.

Direct Costs of Second Aqueous Shunt Implant Versus Transscleral Cyclophotocoagulation (The Assists Trial).

The total direct cost in the SGDD group was more than double that in the CPC group, driven largely by the cost of the study procedure.

Concentration Accuracy of Compounded Mitomycin C for Ophthalmic Surgery.

Common compounding and storage techniques for MMC resulted in a lower accuracy and wider range of concentration than expected.